Innovation in Action: What's next for MRIdian
Sunday, October 25, 12:00 – 12:15 pm ET
Innovation in Action: Real-Time, On-Table Adaptive
Tuesday, October 27, 11:30 – 11:45 am ET
Ad Statistics
Times Displayed: 797
Times Visited: 5 Keep biomedical devices ready to go, so care teams can be ready to care for patients. GE HealthCare’s ReadySee™ helps overcome frustrations due to lack of network and device visibility, manual troubleshooting, and downtime.
Innovation in Action: MRIdian® Solutions for Streamlining Workflow and Improving Efficiency
Monday, October 26, 10:30 – 11:30 am ET
Industry Expert Theater: Maximizing Clinical Value of MRIdian, featuring Dana -Farber/Brigham Women's Cancer Center
Tuesday, October 27, 11:00 am – 12:00 pm ET
To visit ViewRay's virtual booth and for a full schedule of the MRIdian-focused presentations at ASTRO 2020 please visit https://viewray.com/events-webinars. ViewRay's booth will feature information including:
Experience MRIdian: Treat and Prove what Others Can't (Demo and more)
The Patient Experience: Latest Videos
Innovation Value: See What's New with Technology and Treatment
Clinical Value: See the Results
MRIdian in Action: Learn More About our Customer Experience
The Economic Value of MRIdian: The Financial Benefits of Introducing a New Service Line
Additionally, ViewRay will host a physician-led webinar for investors and analysts on Tuesday, October 27, 2020 at 11:00 am ET. Registration is required to attend and will close an hour prior to the start. Please register at https://www.bigmarker.com/viewray/Physician-led-Webinar-for-Investors-and-Analysts-at-2020-ASTRO-Annual-Meeting?utm_bmcr_source=Press.
Currently 40 MRIdian systems are installed at hospitals around the world, where they are used to treat a wide variety of solid tumors and are the focus of numerous ongoing research efforts. MRIdian has been the subject of hundreds of peer-reviewed publications, scientific meeting abstracts and presentations. More than 10,000 patients have been treated with MRIdian. For a list of treatment centers, please visit: https://viewray.com/find-mridian-mri-guided-radiation-therapy/
About ViewRay
ViewRay, Inc. (Nasdaq: VRAY), designs, manufactures and markets the MRIdian radiation therapy system. MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology. Unlike MR systems used in diagnostic radiology, MRIdian's high-definition MR was purpose built to address specific challenges, including beam distortion, skin toxicity, and other concerns that potentially may arise when high magnetic fields interact with radiation beams. ViewRay and MRIdian are registered trademarks of ViewRay, Inc.
SOURCE ViewRay, Inc.
Back to HCB News
